# US 2023/0398117 A1 · 3-hydroxy-N-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)pyrrolidine-1-carboxamide Derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0398117 A1
- Document ID: US20230398117A1
- Status: Published application
- Kind: A1
- Application number: 18/060,796
- Filed: 2022-12-01
- Published: 2023-12-14
- Earliest claimed: 2018-03-26
- Assignees: Novartis AG
- Applicants: Novartis AG
- Inventors: Luca ARISTA; Christina HEBACH; Gregory John HOLLINGWORTH; Philipp HOLZER; Patricia IMBACH-WEESE; Rainer MACHAUER; Niko SCHMIEDEBERG; Anna VULPETTI; Thomas ZOLLER
- Web page: https://patentgrep.com/patent/US20230398117A1

## CPC

- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61P 35/00: Antineoplastic agents
- C07D 487/04: Ortho-condensed systems
- C07D 519/00: Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The invention relates to compounds of the formula (I) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined in the specification; to intermediates in the preparation of the compounds, to pharmaceutical compositions comprising the compounds and to use of the compounds in the treatment of disease.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A compound of Formula (XXIa):
or a salt thereof,
wherein:
R6 is selected from H and F; and
R7 is selected from H, F, Cl, —CH3, —OCH3, and —OCH2CH3.

### Claim 16 (depends on 1)

The compound of claim 1, or a salt thereof, wherein R6 is F.

### Claim 17 (depends on 1)

The compound of claim 1, or a salt thereof, wherein R7 is selected from F, Cl, —CH3, —OCH3, and —OCH2CH3.

### Claim 18 (depends on 1)

The compound of claim 1, or a salt thereof, which is:
or a salt thereof.
